EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Turncoat antibodies unmasked in a model of autoimmune demyelination: From biology to therapy

Reza Taghipour-Mirakmahaleh iD, Françoise Morin iD, Yu Zhang iD, Louis Bourhoven iD, Louis-Charles Béland, Qun Zhou iD, Julie Jaworski iD, Anna Park iD, Juan Manuel Dominguez, Jacques Corbeil iD, Eoin P Flanagan, Romain Marignier iD und 3 weitere

Proceedings of the National Academy of Sciences · 2025

DOI: 10.1073/pnas.2424988122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2025. Verfasst von Reza Taghipour-Mirakmahaleh und 14 weiteren Autor:innen. Beteiligte Einrichtung: Neuroscience Unit, University Hospital Center of Quebec-Laval University, Quebec City, QC G1V 4G2, Canada. Hauptthemen laut MEDLINE: Encephalomyelitis, Autoimmune, Experimental, Autoantibodies, Myelin-Oligodendrocyte Glycoprotein. Die Arbeit nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: CIHR | Institute of Infection and Immunity (III), Multiple Sclerosis Society of Canada (MSSOC), Natural Sciences and Engineering Research Council of Canada (NSERC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Autoantibodies contribute to many autoimmune diseases, yet there is no approved therapy to neutralize them selectively. A popular mouse model, experimental autoimmune encephalomyelitis (EAE), could serve to develop such a therapy, provided we can better understand the nature and importance of the autoantibodies involved. Here, we report the finding of autoantibody-secreting extrafollicular plasmablasts in EAE induced with specific myelin oligodendrocyte glycoprotein (MOG) antigens. Single-cell RNA sequencing reveals that these cells produce nonaffinity-matured IgG antibodies. These include pathogenic antibodies competing for shared binding space on MOG’s extracellular domain. Interestingly, the synthetic anti-MOG antibody 8-18C5 can prevent the binding of pathogenic antibodies from either EAE mice or people with MOG antibody disease. Moreover, an 8-18C5 variant carrying the NNAS mutation, which inactivates its effector functions, can reduce EAE severity and promote functional recovery. In brief, this study provides not only a comprehensive characterization of the humoral response in EAE models but also a proof of concept for a therapy to antagonize pathogenic anti-MOG antibodies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Encephalomyelitis, Autoimmune, ExperimentalAutoantibodiesMyelin-Oligodendrocyte GlycoproteinAnimalsMiceHumansDisease Models, AnimalFemaleImmunoglobulin GMice, Inbred C57BL

Stichwörter der Autor:innen

MOG antibody diseaseantibody-secreting cellsautoantibodydemyelinating autoimmune diseaseexperimental autoimmune disease

Substanzen

AutoantibodiesMyelin-Oligodendrocyte GlycoproteinImmunoglobulin G

Autor:innen und Institutionen

  • Neuroscience Unit, University Hospital Center of Quebec-Laval University, Quebec City, QC G1V 4G2, Canada.
  • Large Molecule Research, Sanofi, Cambridge, MA 02141.
  • Infection and Immunity Unit, Big Data Research Center, University Hospital Center of Quebec-Laval University, Quebec City, QC G1V 4G2, Canada.
  • Department of Neurology, Mayo Clinic, Rochester, MN 55905.
  • Center for Multiple Sclerosis and Autoimmune Neurology, Mayo Clinic, Rochester, MN 55905.
  • Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905.

ORCID-Profile: Reza Taghipour-Mirakmahaleh, Françoise Morin, Yu Zhang, Louis Bourhoven, Qun Zhou, Julie Jaworski, Anna Park, Jacques Corbeil, Romain Marignier, Catherine Larochelle, Steven M Kerfoot, Luc Vallières

Förderung

  • CIHR | Institute of Infection and Immunity (III)
  • Multiple Sclerosis Society of Canada (MSSOC)
  • Natural Sciences and Engineering Research Council of Canada (NSERC)
  • Canada Research Chairs (CRC)
  • HHS | NIH (NIH)

Zitieren

APA

Taghipour-Mirakmahaleh, R., Morin, F., Zhang, Y., Bourhoven, L., Béland, L. C., Zhou, Q., Jaworski, J., Park, A., Dominguez, J. M., Corbeil, J., Flanagan, E. P., Marignier, R., Larochelle, C., Kerfoot, S. M., & Vallières, L. (2025). Turncoat antibodies unmasked in a model of autoimmune demyelination: From biology to therapy. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2424988122

Vancouver

Taghipour-Mirakmahaleh R, Morin F, Zhang Y, Bourhoven L, Béland LC, Zhou Q, et al. Turncoat antibodies unmasked in a model of autoimmune demyelination: From biology to therapy. Proceedings of the National Academy of Sciences. 2025. doi:10.1073/pnas.2424988122

BibTeX
@article{TaghipourMirakmahaleh2025,
  author = {Taghipour-Mirakmahaleh, Reza and Morin, Françoise and Zhang, Yu and Bourhoven, Louis and Béland, Louis-Charles and Zhou, Qun and Jaworski, Julie and Park, Anna and Dominguez, Juan Manuel and Corbeil, Jacques and Flanagan, Eoin P and Marignier, Romain and Larochelle, Catherine and Kerfoot, Steven M and Vallières, Luc},
  title = {Turncoat antibodies unmasked in a model of autoimmune demyelination: From biology to therapy},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2025},
  doi = {10.1073/pnas.2424988122}
}
Kostenlos starten →